Get the Stockscreener App
1.56
5.41%
0.08
Pre-market:
1.56
Ocugen Inc stock is traded at $1.56, with a volume of 2.86M.
It is up +5.41% in the last 24 hours and down -4.29% over the past month.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
See More
Previous Close:
$1.48
Open:
$1.5
24h Volume:
2.86M
Relative Volume:
0.66
Market Cap:
$456.00M
Revenue:
-
Net Income/Loss:
$-63.08M
P/E Ratio:
-5.7778
EPS:
-0.27
Net Cash Flow:
$-72.53M
1W Performance:
-3.11%
1M Performance:
-4.29%
6M Performance:
+108.78%
1Y Performance:
+71.24%
1-Day Range:
$1.49
$1.58
1-Week Range:
$1.47
$1.65
52-Week Range:
$0.515
$1.90
Ocugen Inc Stock (OCGN) Company Profile
Name
Ocugen Inc
Sector
Industry
Phone
484-328-4701
Address
11 GREAT VALLEY PARKWAY, MALVERN, PA
Compare OCGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OCGN
Ocugen Inc
|
1.56 | 462.21M | 0 | -63.08M | -72.53M | -0.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ocugen Inc Stock (OCGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-24 | Initiated | Maxim Group | Buy |
| Mar-01-23 | Upgrade | Chardan Capital Markets | Neutral → Buy |
| Aug-23-22 | Initiated | Mizuho | Buy |
| Jun-15-22 | Resumed | ROTH Capital | Buy |
| Jun-02-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-26-21 | Initiated | Noble Capital Markets | Outperform |
| Jun-11-21 | Downgrade | ROTH Capital | Buy → Neutral |
| May-07-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Feb-09-21 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Feb-04-21 | Upgrade | H.C. Wainwright | Neutral → Buy |
View All
Ocugen Inc Stock (OCGN) Latest News
Is it time to cut losses on Ocugen Inc.Weekly Market Outlook & Expert Curated Trade Setups - newser.com
Will Ocugen Inc. stock outperform tech sector in 20252025 Top Gainers & Risk Managed Trade Strategies - newser.com
Using economic indicators to assess Ocugen Inc. potentialMarket Sentiment Review & Free High Return Stock Watch Alerts - newser.com
Is Ocugen Inc. stock ready for breakoutJuly 2025 Recap & Reliable Entry Point Trade Alerts - newser.com
Analyzing net buyer seller activity in Ocugen Inc.Weekly Investment Report & Technical Confirmation Alerts - newser.com
Is Ocugen Inc. (2H51) stock a top dividend aristocrat candidateTrade Risk Summary & Long-Term Safe Investment Ideas - newser.com
Will Ocugen Inc. stock see insider buyingJuly 2025 Movers & Safe Capital Growth Trade Ideas - newser.com
Is Ocugen Inc. (2H51) stock resilient in recession scenariosMarket Sentiment Report & Real-Time Volume Analysis - newser.com
Why Ocugen Inc. (2H51) stock trades below fair value2025 Risk Factors & Long-Term Growth Portfolio Plans - newser.com
How Ocugen Inc. (2H51) stock trades pre earnings2025 Support & Resistance & Free Technical Pattern Based Buy Signals - newser.com
What Catalysts Could Shift the Ocugen Narrative Amid New Developments and Analyst Debates - Yahoo Finance
Identifying reversal signals in Ocugen Inc.Quarterly Risk Review & Weekly Momentum Stock Picks - newser.com
How high can Ocugen Inc. stock goJuly 2025 Technicals & Verified Momentum Stock Watchlist - newser.com
Will Ocugen Inc. stock maintain dividend yieldBond Market & AI Powered Market Trend Analysis - newser.com
How Ocugen Inc. stock reacts to job market dataJuly 2025 Sector Moves & Verified Short-Term Plans - newser.com
Is Ocugen Inc. stock attractive for growth ETFs2025 Major Catalysts & Community Trade Idea Sharing - newser.com
What drives Ocugen Inc 2H51 stock priceSector Leadership Analysis & Minimal Investment Trading Tips - earlytimes.in
Best data tools to analyze Ocugen Inc. stockGap Up & Entry Point Strategy Guides - newser.com
Ocugen to Announce Third-Quarter 2025 Results and Business Update on November 5 - MyChesCo
Combining price and volume data for Ocugen Inc.2025 Retail Activity & Target Return Focused Stock Picks - newser.com
Is Ocugen Inc. still worth holding after the dipJuly 2025 EndofMonth & Accurate Entry and Exit Point Alerts - newser.com
Will Ocugen Inc. stock reach Wall Street targetsWeekly Trend Report & Accurate Intraday Trading Signals - newser.com
Price momentum metrics for Ocugen Inc. explained2025 Technical Overview & Smart Investment Allocation Tips - newser.com
Why millennials buy Ocugen Inc. (2H51) stockJuly 2025 Action & Community Consensus Stock Picks - newser.com
Ocugen (OCGN) to Release Quarterly Earnings on Wednesday - MarketBeat
Ocugen Inc Stock (OCGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):